Situation

When Crestor (Rosuvastatine) arrived to Mexico, the statine market was more than competed, which is why it faced the disloyal attack of many of its competitors, among them Pfizer, which launched a campaign to impede the positioning of Rosuvastatine in our country.

Strategy

Due to this, several communication actions were established, in order to stop the disloyal attack and promote truthful information, always supported by investigation.

Results

Currently, Crestor is one of AstraZeneca's leading products worldwide, including our country.

On a medical level, it is spearhead in investigation, being the only drug that has been able to reverse the coronary arterial illness, which means a magnificent advancement in medical science.